Nissan Medical Industries Ltd (TLV:NISA)
901.10
-38.90 (-4.14%)
Mar 9, 2026, 5:24 PM IDT
Nissan Medical Industries Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 85 | 116 | 98 | 78 | 199 | 260 | Upgrade
|
| Market Cap Growth | -24.22% | 18.15% | 25.68% | -60.78% | -23.34% | 112.17% | Upgrade
|
| Enterprise Value | 365 | 413 | 431 | 433 | 525 | 594 | Upgrade
|
| Last Close Price | 9.37 | 10.78 | 8.67 | 6.90 | 17.26 | 21.76 | Upgrade
|
| PE Ratio | 85085.37 | 14.66 | 17.37 | - | 5.53 | 4.57 | Upgrade
|
| PS Ratio | 0.13 | 0.18 | 0.13 | 0.11 | 0.30 | 0.36 | Upgrade
|
| PB Ratio | 0.27 | 0.33 | 0.28 | 0.24 | 0.58 | 0.80 | Upgrade
|
| P/TBV Ratio | 0.52 | 0.60 | 0.51 | 0.44 | 1.18 | 1.73 | Upgrade
|
| P/FCF Ratio | 5.49 | 5.59 | 1.02 | 31.30 | 20.27 | 2.39 | Upgrade
|
| P/OCF Ratio | 2.48 | 4.32 | 0.93 | 6.69 | 11.07 | 2.12 | Upgrade
|
| EV/Sales Ratio | 0.57 | 0.62 | 0.59 | 0.63 | 0.79 | 0.82 | Upgrade
|
| EV/EBITDA Ratio | 9.88 | 7.79 | 4.96 | 16.09 | 5.75 | 4.31 | Upgrade
|
| EV/EBIT Ratio | 43.89 | 13.92 | 7.02 | - | 7.98 | 5.38 | Upgrade
|
| EV/FCF Ratio | 23.53 | 19.91 | 4.49 | 173.44 | 53.48 | 5.47 | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.57 | 0.56 | 0.76 | 0.70 | 0.74 | Upgrade
|
| Debt / EBITDA Ratio | 5.47 | 3.41 | 2.14 | 9.34 | 2.63 | 1.75 | Upgrade
|
| Debt / FCF Ratio | 12.21 | 9.76 | 2.07 | 100.67 | 24.53 | 2.21 | Upgrade
|
| Net Debt / Equity Ratio | 0.52 | 0.52 | 0.49 | 0.70 | 0.58 | 0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.80 | 3.50 | 1.99 | 8.61 | 2.20 | 1.39 | Upgrade
|
| Net Debt / FCF Ratio | 10.58 | 8.93 | 1.81 | 92.85 | 20.44 | 1.76 | Upgrade
|
| Asset Turnover | 0.93 | 0.94 | 1.02 | 0.93 | 0.93 | 1.04 | Upgrade
|
| Inventory Turnover | 4.12 | 3.98 | 5.40 | 5.66 | 6.44 | 8.64 | Upgrade
|
| Quick Ratio | 0.47 | 0.38 | 0.62 | 0.66 | 0.74 | 0.71 | Upgrade
|
| Current Ratio | 0.93 | 1.11 | 1.16 | 1.17 | 1.34 | 1.00 | Upgrade
|
| Return on Equity (ROE) | -0.07% | 3.89% | 5.54% | -13.99% | 17.11% | 31.05% | Upgrade
|
| Return on Assets (ROA) | 0.54% | 2.62% | 5.32% | -0.15% | 5.75% | 9.92% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.22% | 5.06% | 7.70% | -0.32% | 10.07% | 17.59% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.60% | 6.50% | 12.70% | -0.30% | 12.20% | 21.80% | Upgrade
|
| Earnings Yield | 0.00% | 6.82% | 5.76% | -46.18% | 18.09% | 21.90% | Upgrade
|
| FCF Yield | 18.23% | 17.90% | 97.75% | 3.19% | 4.93% | 41.87% | Upgrade
|
| Dividend Yield | 19.36% | 6.96% | - | - | 2.55% | 4.59% | Upgrade
|
| Payout Ratio | 681300.00% | 86.17% | - | - | 25.22% | 17.58% | Upgrade
|
| Total Shareholder Return | 25.81% | 6.96% | - | - | 2.55% | 4.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.